Why people should get involved with clinical trials

An episode of the Chatting With Betsy podcast, hosted by Betsy Wurzel, titled "Why people should get involved with clinical trials" was published on December 22, 2022 and runs 35 minutes.

December 22, 2022 ·35m · Chatting With Betsy

0:00 / 0:00

Summary

Today's guest is James Geraghty, Author, and Writer of "INSIDE THE ORPHAN DRUG REVOLUTION": THE PROMISE OF PATIENT-CENTERED BIOTECHNOLOGY. James discusses why he wrote this book, what orphan drugs are, gave examples of rare diseases, and discussed stories about parents who advocated for their children to have orphan medications to help their children.James Geraghty discussed gene editing, genetic therapies, and why people should get involved with clinical trials!We also discussed the future of treatment for Alzheimer's! In Betsy's opinion, James Geraghty has a heart and a fierce passion for orphan drugs and the families that he has met!James Geraghty has been a Director of eight NASDAQ-Listed biotech companies and chair of Five.James has worked on orphan drugs for over 40 years as a strategy consultant, a CEO, a leader of pioneering international operations at Genzyme, and a venture entrepreneur!Become a supporter of this podcast: https://www.spreaker.com/podcast/chatting-with-betsy--4211847/support.💡 At Passionate World Talk Radio, we believe real conversations matter. Stay inspired and keep listening to Chatting with Betsy at www.passionateworldtalkradio.com.

Episode Description

Today's guest is James Geraghty, Author, and Writer of "INSIDE THE ORPHAN DRUG REVOLUTION": THE PROMISE OF PATIENT-CENTERED BIOTECHNOLOGY.
James discusses why he wrote this book, what orphan drugs are, gave examples of rare diseases, and discussed stories about parents who advocated for their children to have orphan medications to help their children.

James Geraghty discussed gene editing, genetic therapies, and why people should get involved with clinical trials!
We also discussed the future of treatment for Alzheimer's! In Betsy's opinion, James Geraghty has a heart and a fierce passion for orphan drugs and the families that he has met!

James Geraghty has been a Director of eight NASDAQ-Listed biotech companies and chair of Five.
James has worked on orphan drugs for over 40 years as a strategy consultant, a CEO, a leader of pioneering international operations at Genzyme, and a venture entrepreneur!

Become a supporter of this podcast: https://www.spreaker.com/podcast/chatting-with-betsy--4211847/support.

💡 At Passionate World Talk Radio, we believe real conversations matter. Stay inspired and keep listening to Chatting with Betsy at www.passionateworldtalkradio.com.